Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-2,199
Closed -$143K – 965
2021
Q3
$143K Sell
2,199
-550
-20% -$33.6K 0.01% 354
2021
Q2
$167K Hold
2,749
– – 0.01% 339
2021
Q1
$148K Hold
2,749
– – 0.01% 333
2020
Q4
$132K Hold
2,749
– – 0.01% 337
2020
Q3
$108K Sell
2,749
-64
-2% -$2.33K 0.01% 340
2020
Q2
$90.3K Buy
2,813
+64
+2% +$2.23K 0.01% 348
2020
Q1
$93.3K Hold
2,749
– – 0.01% 308
2019
Q4
$132K Hold
2,749
– – 0.01% 301
2019
Q3
$137K Hold
2,749
– – 0.01% 288
2019
Q2
$147K Sell
2,749
-66
-2% -$3.45K 0.01% 284
2019
Q1
$149K Hold
2,815
– – 0.02% 276
2018
Q4
$132K Hold
2,815
– – 0.02% 276
2018
Q3
$162K Buy
2,815
+266
+10% +$14.7K 0.02% 277
2018
Q2
$139K Sell
2,549
-680
-21% -$33.7K 0.02% 301
2018
Q1
$153K Buy
+3,229
New +$162K 0.02% 274

Other funds holding NTR

RBC Europe's NTR Position: Q4 2021 in Review

RBC Europe sold out of Nutrien (NTR) in Q4 2021, closing a stake of 2,199 shares — an estimated $143K sold.

RBC Europe first reported a position in NTR in Q1 2018 and held it in 15 quarters. The position peaked at $167K in Q2 2021. 665 funds tracked by Wall St. Rank hold NTR as of Q4 2021.

  • RBC Europe reported no remaining Nutrien position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 2,199 Nutrien shares in Q4 2021, an estimated $143K.
  • RBC Europe first reported a position in Nutrien in Q1 2018 and held it in 15 quarters.
  • RBC Europe's Nutrien position peaked at $167K in Q2 2021.
  • 665 funds tracked by Wall St. Rank held Nutrien as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.